Philip Hewitt

Merck & Co. Inc.

Philip Hewitt is listed at Merck & Co. Inc.. Philip is scheduled to speak at SOT 66th Annual Meeting and ToxExpo 2027 on 17 March 2027.

Compiled from published conference agendas; not yet confirmed by Philip. Is this you? Claim this profile.

Upcoming

SOT 66th Annual Meeting and ToxExpo 2027 14 March 2027 – 17 March 2027

• Cracking the Code: Using NAMs to Unmask Molecular Mechanisms of Toxicity and Bridge the Species Gap Speaker · 17 March 2027
• From Innovation to Integration: Implementing NAMs for Human Risk Assessment in Drug Discovery Toxicology Speaker · 17 March 2027

Spoke alongside

People who have shared a session with Philip at events on B2DB.

• Amy Mihalchik ToxStrategies LLC 1 shared session
• Kimberley Homan Genentech Inc. 1 shared session
• Nakissa Sadrieh US FDA 1 shared session
• Wenyue (Wendy) Hu Vividion Therapeutics 1 shared session
• Will Proctor GSK 1 shared session